1991
DOI: 10.1016/0192-0561(91)90034-5
|View full text |Cite
|
Sign up to set email alerts
|

Protection against influenza a virus infection in mice by oral immunization with a polyvalent bacterial lysate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

1992
1992
2014
2014

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 39 publications
0
10
0
Order By: Relevance
“…This concept has been explored as an alternative to the traditional influenza virus vaccine [97,98]. In mice, oral immunization with bacterial lysate composed of antigens derived from S. aureus, Streptococcus pyogenes, S. pneumoniae, Streptococcus mitis, Klebsiella pneumoniae, Moraxella catarrhalis and Haemophilus influenzae reduces mortality due to influenza virus infection [97].…”
Section: Inhibitory Effects Of S Pneumoniae On Viral Replicationmentioning
confidence: 99%
“…This concept has been explored as an alternative to the traditional influenza virus vaccine [97,98]. In mice, oral immunization with bacterial lysate composed of antigens derived from S. aureus, Streptococcus pyogenes, S. pneumoniae, Streptococcus mitis, Klebsiella pneumoniae, Moraxella catarrhalis and Haemophilus influenzae reduces mortality due to influenza virus infection [97].…”
Section: Inhibitory Effects Of S Pneumoniae On Viral Replicationmentioning
confidence: 99%
“…Wc recently demonstrated that oral immunization with a bacterial lysate significantly reduces mortality in mice in fected with Streptococcus pneumoniae [1,2] or influenza A virus [2,3]. One of the protective mechanisms of oral im munization, apart from induction of specific immunity [for review see 4], might be limitation of the alveolar inflam matory reaction after infection and thereby reduction of pulmonary damage.…”
Section: Introductionmentioning
confidence: 99%
“…Taken together, our data indicate that the administration of LW50020 via the oral route results in a protective immunological reaction at least against the Klebsiella component of the preparation. Nonspecific effects of the lysate have also been described [18,21], but obviously these do not play a major role in the enhanced resistance against Klebsiella. It would be interesting to know whether the Klebsiella component is also involved in the enhanced, nonspecific resistance induced by heptavalent vaccine e.g.…”
Section: Discussionmentioning
confidence: 99%